Evidence map›Paper›PMID 40563640›Full record

ArticleCancers2025

Antitumor Effect of mTOR1/2 Dual Inhibitor AZD8055 in Canine Pulmonary Carcinoma.

Tomokazu Nagashima, Kazuhiko Ochiai, Yuka Takizawa, Youta Koike, Takahiro Saito, Asumi Muramatsu, Daigo Azakami, Yukino Machida, Makoto Bonkobara, Toshiyuki Ishiwata and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tomokazu NagashimaDepartment of Veterinary Pathology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo 180-8602, Japan.
Kazuhiko OchiaiLaboratory of Veterinary Hygiene, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo 180-8602, Japan.ORCID 0000-0002-5736-0598
Yuka TakizawaLaboratory of Clinical Oncology, Tokyo University of Agriculture and Technology, Tokyo 183-8538, Japan.
Youta KoikeLaboratory of Clinical Oncology, Tokyo University of Agriculture and Technology, Tokyo 183-8538, Japan.
Takahiro SaitoLaboratory of Clinical Oncology, Tokyo University of Agriculture and Technology, Tokyo 183-8538, Japan.
Asumi MuramatsuDepartment of Veterinary Pathology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo 180-8602, Japan.
Daigo AzakamiLaboratory of Clinical Oncology, Tokyo University of Agriculture and Technology, Tokyo 183-8538, Japan.
Yukino MachidaDepartment of Veterinary Pathology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo 180-8602, Japan.
Makoto BonkobaraLaboratory of Veterinary Clinical Pathology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo 180-8602, Japan.
Toshiyuki IshiwataDivision of Aging and Carcinogenesis, Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo 173-0015, Japan.
Masaki MichishitaDepartment of Veterinary Pathology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo 180-8602, Japan.

Funding

KAKENHI Scientific Research Grants from the Ministry 397 of Education, Culture, Sports, Science, and Technology of Japan 22K05996, 25K02181
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AZD8055caninelungmTORPI3K/AKT/mTOR pathwaypulmonary adenocarcinoma

Identifiers

PMID40563640
PMCPMC12190952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.